UTI Earnings Prediction
The chart below shows how UTI performed 10 days before and after its earnings report, based on data from the past quarters. Typically, UTI sees a -2.47% change in stock price 10 days leading up to the earnings, and a +5.93% change 10 days following the report. On the earnings day itself, the stock moves by -0.38%. This data can give you a slight idea of what to expect for the next quarter's release.
UTI Key Earning Data
UTI Earnings Analysis
Positive
Q2 Revenue Increase: Revenue for Q2 increased nearly 13% year-over-year to $207.4 million.
Student Enrollment Growth: Average full-time active students grew over 10% year-over-year to 24,604 students.
Student Enrollment Increase: New student starts grew more than 21% year-over-year, reaching 6,650 starts.
Net Income Surge: Net income increased 47% to $11.4 million with diluted earnings per share of $0.21.
EBITDA Growth Achievement: Adjusted EBITDA grew approximately 28% year-over-year to $28.9 million.
Student Enrollment Growth: Concorde division saw a 15.5% increase in average full-time active students and a 15.9% increase in new student starts.
Student Enrollment Growth: UTI division generated a 7% increase in average full-time active students and a 26.4% increase in new student starts.
Fiscal 2025 Revenue Guidance: The company raised its fiscal 2025 revenue guidance to between $825 million and $835 million, reflecting approximately 13% year-over-year growth.
Adjusted EBITDA Guidance Increase: Adjusted EBITDA guidance for fiscal 2025 was raised to between $124 million and $128 million, a 23% year-over-year increase at the midpoint.
New Program Launch Commitment: The company is committed to launching at least six new programs each year across Concorde and/or UTI campuses, pending regulatory approval.
Negative
Student Retention Challenges: Despite strong revenue growth, the UTI division only saw a 7% increase in average full-time active students, indicating potential challenges in student retention or recruitment compared to the Concorde division's performance.
EBITDA Growth Outlook: The company anticipates that EBITDA growth will slow in fiscal 2026 and 2027 due to increased investments, suggesting a temporary dip in profitability despite long-term growth plans.
Student Enrollment Growth Trends: New student starts in Q3 are expected to grow in the mid to upper single digits, and Q4 is likely to see low single-digit growth, indicating a potential slowdown in growth momentum as compared to previous quarters.
EBITDA Margin Uncertainty: The company has acknowledged that their EBITDA margins will not be linear due to the investments being made, which could lead to uncertainty in financial performance in the near term.
UTI FAQs
How does UTI typically perform around its earnings report dates?
UTI's stock performance around earnings reports can vary, but historical data shows specific patterns, such as a -2.47% change leading up to the report and a +5.93% change in the 10 days following the release.
Is Universal Technical Institute Inc (UTI) Q2 2025 Earnings Call Summary positive or negative?
How can historical earnings data help predict future stock performance?
UTI Earning Call Sentiment
Universal Technical Institute, Inc. (NYSE:UTI) Q2 2025 Earnings Call Transcript
UTI.N
-7.23%
